Getinge Interim Report January-June 2016

Second quarter of 2016 in brief

  ·  Order intake: -0.7% to SEK 7,460 M (7,516). The order intake grew
organically by 3.0%.
  ·  Net sales: -3.5% to SEK 6,927 M (7,181). Net sales fell organically by
0.3%.
  ·  Gross margin: 45.7% (46.4). Affected negatively by currencies.
  ·  EBITA*: +10.2% to SEK 788 M (715).
  ·  Restructuring and integration costs: SEK 133 M (86).
  ·  Profit before tax: +28.0% to SEK 311 M (243).
  ·  Earnings per share: SEK 0.93 (0.71).
  ·  Good cost control: Administrative and selling expenses declined by 8.4%.
  ·  New President of Acute Care Therapies: Jens Viebke
  ·  FDA update: Getinge is still awaiting a decision by the FDA regarding the
remediation plan in Hechingen.
  ·  Strengthened customer offering: Launches include a new mobile operating
table.

January-June 2016 in brief

  ·  Order intake: -2.2% to SEK 14,384 M (14,708). The order intake grew
organically by 0.5%.
  ·  Net sales: -4.2% to SEK 13,304 M (13,893). Net sales fell organically by
1.7%.
  ·  Gross margin: 46.4% (46.6).
  ·  EBITA*: -1.7% to SEK 1,408 M (1,432).
  ·  Restructuring and integration costs: SEK 260 M (270).
  ·  Profit before tax: +20.6% to SEK 468 M (388).
  ·  Earnings per share: SEK 1.39 (1.09).
  ·  The transformation and efficiency-enhancement program was initiated and a
Group-wide sales organization was established.

Financial summary

MSEK        Q2 2016            Q2     Change  Jan-Jun    Jan     Change  Rolling
12M     FY
                               2015   %       2016       -Jun    %
2015
                                                         2015
Order       7 460              7 516  -0.7%   14 384     14 708  -2.2%   30 107
30
intake
431
Net sales   6 927              7 181  -3.5%   13 304     13 893  -4.2%   29 646
30

235
Gross       3 167              3 331  -4.9%   6 178      6 473   -4.6%   13 868
14
Profit
163
Gross       45.7%              46.4%  -0.7%   46.4%      46.6%   -0.2%   46.8%
46.8%
margin
EBITA*      788                715    10.2%   1 408      1 432   -1.7%   4 155
4 179
EBITA       11.4%              10.0%  1.4%    10.6%      10.3%   0.3%    14.0%
13.8%
margin*
Operating   473                428    10.5%   789        762     3.5%    2 756
2 729
profit
Profit      311                243    28.0%   468        388     20.6%   2 077
1 997
before tax
Net profit  227                177    28.2%   342        283     20.8%   1 516
1 457
Earnings    0.93               0.71   31.0%              1.09    27.5%
                5.83
per                                           1.39                       6.13
share
Cash flow   463                598    -22.6%  1 163      1 252   -7.1%
             3  3 458
from                                                                     369
operations


























* before restructuring, acquisition and integration cost

Getinge Group is a leading global provider of innovative solutions for operating
rooms, intensive-care units, hospital wards, sterilization departments, elderly
care and for life science companies and institutions. With a genuine passion for
life we build quality and safety into every system. Our unique value proposition
mirrors the continuum of care, enhancing efficiency throughout the clinical
pathway. Based on our first-hand experience and close partnerships, we are able
to exceed expectations from customers – improving the every-day life for people,
today and tomorrow.

The information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading Act.